Impaired therapeutic vasculogenesis by transplantation of OxLDL-treated endothelial progenitor cells

Journal of Lipid Research

Volumn 48, Issue 3, 2007, Pages 518-527

  Zhou, Bin ^a   Feng, Xia Ma ^a   Peng, Xia Liu ^a   Zhi, Hong Fang ^a   Si, Li Wang ^a   Zhi, Bo Han ^a   Poon, Man Chiu ^a,b   Zhong, Chao Han ^a  

^a INSTITUTE OF HEMATOLOGY AND BLOOD DISEASES HOSPITAL   (China)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

Ischemia; Oxidized low density lipoprotein; Stromal cell derived factor

Indexed keywords

OXIDIZED LOW DENSITY LIPOPROTEIN; STROMAL CELL DERIVED FACTOR 1;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY DENSITY; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; LASER DOPPLER FLOWMETRY; LIMB ISCHEMIA; MALE; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; SURGICAL TECHNIQUE;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL ADHESION; CELL DIFFERENTIATION; CELL MOVEMENT; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; HINDLIMB; HUMANS; ISCHEMIA; LIPOPROTEINS, LDL; MALE; MICE; MICE, NUDE; NEOVASCULARIZATION, PHYSIOLOGIC; STEM CELL TRANSPLANTATION; STEM CELLS; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33947178943     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M600251-JLR200     Document Type: Article

References (27)

1. Cao, Y., A. Hong, H. Schulten, and M. J. Post. 2005. Update on therapeutic neovascularization. Cardiovasc. Res. 65: 639-648.
2. Kawamoto, A., T. Asahara, and D. W. Losordo. 2002. Transplantation of endothelial progenitor cells for therapeutic neovascularization. Cardiovasc. Radiat. Med. 3: 221-225.
3. Asahara, T., T. Murohara, A. Sullivan, M. Silver, R. van der Zee, T. Li, B. Witzenbichler, G. Schatteman, and J. M. Isner. 1997. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 275: 964-967.
4. Kalka, C., H. Masuda, T. Takahashi, W. M. Kalka-Moll, M. Silver, M. Kearney, T. Li, J. M. Isner, and T. Asahara. 2000. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc. Natl. Acad. Sci. USA. 97: 3422-3427.
5. Yang, C., Z. H. Zhang, Z. J. Li, R. C. Yang, G. Q. Qian, and Z. C. Han. 2004. Enhancement of neovascularization with cord blood CD1331 cell-derived endothelial progenitor cell transplantation. Thromb. Haemost. 91: 1202-1212.
6. Vasa, M., S. Fichtlscherer, A. Aicher, K. Adler, C. Urbich, H. Martin, A. M. Zeiher, and S. Dimmeler. 2001. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ. Res. 89: E1-E7.
7. Hill, J. M., G. Zalos, J. P. Halcox, W. H. Schenke, M. A. Waclawiw, A. A. Quyyumi, and T. Finkel. 2003. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N. Engl. J. Med. 348: 593-600.
8. Schmidt-Lucke, C., L. Rossig, S. Fichtlscherer, M. Vasa, M. Britten, U. Kamper, S. Dimmeler, and A. M. Zeiher. 2005. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation. 111: 2981-2987.
9. Imanishi, T., T. Hano, Y. Matsuo, and I. Nishio. 2003. Oxidized low-density lipoprotein inhibits vascular endothelial growth factor-induced endothelial progenitor cell differentiation. Clin. Exp. Pharmacol. Physiol. 30: 665-670.
10. Imanishi, T., T. Hano, T. Sawamura, and I. Nishio. 2004. Oxidized low-density lipoprotein induces endothelial progenitor cell senescence, leading to cellular dysfunction. Clin. Exp. Pharmacol. Physiol. 31: 407-413.
11. Wang, X., J. Chen, Q. Tao, J. Zhu, and Y. Shang. 2004. Effects of ox-LDL on number and activity of circulating endothelial progenitor cells. Drug Chem. Toxicol. 27: 243-255.
12. Ma, F. X., B. Zhou, Z. Chen, Q. Ren, S. H. Lu, T. Sawamura, and Z. C. Han. 2006. Oxidized low density lipoprotein impairs endothelial progenitor cells by regulation of endothelial nitric oxide synthase. J. Lipid Res. 47: 1227-1237.
13. Couffinhal, T., M. Silver, L. P. Zheng, M. Kearney, B. Witzenbichler, and J. M. Isner. 1998. Mouse model of angiogenesis. Am. J. Pathol. 152: 1667-1679.
14. Kinnaird, T., E. Stabile, M. S. Burnett, M. Shou, C. W. Lee, S. Barr, S. Fuchs, and S. E. Epstein. 2004. Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation. 109: 1543-1549.
15. Murohara, T., T. Asahara, M. Silver, C. Bauters, H. Masuda, C. Kalka, M. Kearney, D. Chen, J. F. Symes, M. C. Fishman, et al. 1998. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J. Clin. Invest. 101: 2567-2578.
16. Murohara, T., H. Ikeda, J. Duan, S. Shintani, K. Sasaki, H. Eguchi, I. Onitsuka, K. Matsui, and T. Imaizumi. 2000. Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J. Clin. Invest. 105: 1527-1536.
17. Assmus, B., V. Schachinger, C. Teupe, M. Britten, R. Lehmann, N. Dobert, F. Grunwald, A. Aicher, C. Urbich, H. Martin, et al. 2002. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation. 106: 3009-3017.
18. Shi, Q., S. Rafii, M. H. Wu, E. S. Wijelath, C. Yu, A. Ishida, Y. Fujita, S. Kothari, R. Mohle, L. R. Sauvage, et al. 1998. Evidence for circulating bone marrow-derived endothelial cells. Blood. 92: 362-367.
19. Takahashi, T., C. Kalka, H. Masuda, D. Chen, M. Silver, M. Kearney, M. Magner, J. M. Isner, and T. Asahara. 1999. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat. Med. 5: 434-438.
20. Yamaguchi, J., K. F. Kusano, O. Masuo, A. Kawamoto, M. Silver, S. Murasawa, M. Bosch-Marce, H. Masuda, D. W. Losordo, J. M. Isner, et al. 2003. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation. 107: 1322-1328.
21. Grunewald, M., I. Avraham, Y. Dor, E. Bachar-Lustig, A. Itin, S. Jung, S. Chimenti, L. Landsman, R. Abramovitch, and E. Keshet. 2006. VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells. Cell. 124: 175-189.
22. Asahara, T., T. Takahashi, H. Masuda, C. Kalka, D. Chen, H. Iwaguro, Y. Inai, M. Silver, and J. M. Isner. 1999. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J. 18: 3964-3972.
23. Tepper, O. M., R. D. Galiano, J. M. Capla, C. Kalka, P. J. Gagne, G. R. Jacobowitz, J. P. Levine, and G. C. Gurtner. 2002. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation. 106: 2781-2786.
24. De Falco, E., D. Porcelli, A. R. Torella, S. Straino, M. G. Iachininoto, A. Orlandi, S. Truffa, P. Biglioli, M. Napolitano, M. C. Capogrossi, et al. 2004. SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells. Blood. 104: 3472-3482.
25. Hiasa, K., M. Ishibashi, K. Ohtani, S. Inoue, Q. Zhao, S. Kitamoto, M. Sata, T. Ichiki, A. Takeshita, and K. Egashira. 2004. Gene transfer of stromal cell-derived factor-1alpha enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovascularization. Circulation. 109: 2454-2461.
26. Werner, N., S. Kosiol, T. Schiegl, P. Ahlers, K. Walenta, A. Link, M. Bohm, and G. Nickenig. 2005. Circulating endothelial progenitor cells and cardiovascular outcomes. N. Engl. J. Med. 353: 999-1007.
27. Shimada, K., H. Mokuno, E. Matsunaga, T. Miyazaki, K. Sumiyoshi, A. Kume, K. Miyauchi, and H. Daida. 2004. Predictive value of circulating oxidized LDL for cardiac events in type 2 diabetic patients with coronary artery disease. Diabetes Care. 27: 843-844.